MENU
ABCL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AbCellera Biologics (ABCL) Ownership - Who owns AbCellera Biologics?
AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more
Profile
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
611.89M
P/E Ratio
N/A
Total Cash
605.27M
Projected Growth
N/A
Total Debt
67.85M
Revenue
23.11M
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
2.03
Total Debt/Equity
N/A
Revenue/Share
0.08 USD as % of share price
Fundamentals
ABCL
Capitalization
612M
P/E Ratio
N/A
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
605M
Total Cash/Share
2.03
Total Debt
67.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.08%
Revenue
23.1M
ROE
N/A
Book Value
1.02B
P/B Ratio
0.60
Cash Flow
N/A
Earnings
-0.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
790M
Current Ratio
10.15
Current Revenue Per Employee
7105.70
Dividends Per Share - Security
N/A
EBITDA
-211.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-11.96
Shares Held By Institutions
2.54B
Shares Outstanding - Current
298M
Total Liabilities
321M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-30.034
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com